143 related articles for article (PubMed ID: 28521201)
1. Validation of the use of an artificial mitochondrial reporter DNA vector containing a Cytomegalovirus promoter for mitochondrial transgene expression.
Yamada Y; Ishikawa T; Harashima H
Biomaterials; 2017 Aug; 136():56-66. PubMed ID: 28521201
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial transgene expression via an artificial mitochondrial DNA vector in cells from a patient with a mitochondrial disease.
Ishikawa T; Somiya K; Munechika R; Harashima H; Yamada Y
J Control Release; 2018 Mar; 274():109-117. PubMed ID: 29408532
[TBL] [Abstract][Full Text] [Related]
3. Validation of Mitochondrial Gene Delivery in Liver and Skeletal Muscle via Hydrodynamic Injection Using an Artificial Mitochondrial Reporter DNA Vector.
Yasuzaki Y; Yamada Y; Ishikawa T; Harashima H
Mol Pharm; 2015 Dec; 12(12):4311-20. PubMed ID: 26567847
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL; Hitt M; Kunsken D; Graham FL
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1653-61. PubMed ID: 9225042
[TBL] [Abstract][Full Text] [Related]
5. Correlation between the levels of survivin and survivin promoter-driven gene expression in cancer and non-cancer cells.
Konopka K; Spain C; Yen A; Overlid N; Gebremedhin S; Düzgüneş N
Cell Mol Biol Lett; 2009; 14(1):70-89. PubMed ID: 18839071
[TBL] [Abstract][Full Text] [Related]
6. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter.
Harms JS; Splitter GA
Hum Gene Ther; 1995 Oct; 6(10):1291-7. PubMed ID: 8590733
[TBL] [Abstract][Full Text] [Related]
8. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
9. p53 Status and gene transfer experiments using CMV enhancer/promoter.
Allamane S; Ratel D; Jourdes P; Berger F; Benabid AL; Wion D
Biochem Biophys Res Commun; 2001 Jan; 280(1):45-7. PubMed ID: 11162475
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of TTR and CMV promoters in vivo and in vitro via a secreted luciferase reporter system].
Luo ST; Tian WH; Wang G; Dong XY; Yang L; Wu XB
Bing Du Xue Bao; 2009 Nov; 25(6):424-9. PubMed ID: 20077932
[TBL] [Abstract][Full Text] [Related]
11. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
[TBL] [Abstract][Full Text] [Related]
12. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
13. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
14. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
15. Transgene expression in the brain stem effected by intramuscular injection of polyethylenimine/DNA complexes.
Wang S; Ma N; Gao SJ; Yu H; Leong KW
Mol Ther; 2001 May; 3(5 Pt 1):658-64. PubMed ID: 11356070
[TBL] [Abstract][Full Text] [Related]
16. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
17. Conventional plasmid DNAs with a CpG-containing backbone achieve durable transgene expression in mouse liver.
Suzuki T; Wakao Y; Goda T; Kamiya H
J Gene Med; 2020 Jan; 22(1):e3138. PubMed ID: 31696985
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte-specific gene expression from integrated lentiviral vectors.
Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of transgene expression by cotransfection of oriP plasmid with EBNA-1 expression vector.
Kaneda Y; Saeki Y; Nakabayashi M; Zhou WZ; Kaneda MW; Morishita R
Hum Gene Ther; 2000 Feb; 11(3):471-9. PubMed ID: 10697121
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.
Tang DC; Jennelle RS; Shi Z; Garver RI; Carbone DP; Loya F; Chang CH; Curiel DT
Hum Gene Ther; 1997 Nov; 8(17):2117-24. PubMed ID: 9414259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
